• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » David Simmons of PPD Elected 2016 ACRO Chairman

David Simmons of PPD Elected 2016 ACRO Chairman

January 7, 2016
CenterWatch Staff

 The Association of Clinical Research Organizations (ACRO) has elected David Simmons, chairman and chief executive officer of PPD, as its 2016 chairman, and John Hubbard, president and chief executive officer of BioClinica, as vice chairman.

“ACRO plays a vital role in promoting the interests of the CRO industry globally,” said Simmons. “Not only does ACRO represent the industry on legislative and regulatory matters but, increasingly, the association helps build relationships with the sponsor, research site, investigator and patient communities. I look forward to leading the organization in 2016 as we pursue a focused and productive agenda.”   

Simmons added that, in addition to its legislative and regulatory priorities, ACRO is exploring further ways to benefit the industry in areas such as patient recruitment, workforce development and clinical trial efficiency.

“ACRO successfully advanced CRO industry interests in 2015 by influencing health and tax policy in the U.S. and navigating the implementation of the Clinical Trial Regulation in the European Union,” said ACRO Executive Director Doug Peddicord, Ph.D. “We will build on our successes this year and continue to promote our industry through our robust communications and advocacy programs.”

ACRO also elected as officers: Judd Hartman, general counsel of PPD, as Treasurer; and Maria Kraus, executive vice president of corporate development and strategy at BioClinica, as secretary.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing